<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04340037</url>
  </required_header>
  <id_info>
    <org_study_id>2019S1035v2</org_study_id>
    <nct_id>NCT04340037</nct_id>
  </id_info>
  <brief_title>Prediction of Sepsis After Percutaneous Nephrolithotomy</brief_title>
  <official_title>A Pre-operative Nomogram for Sepsis After Percutaneous Nephrolithotomy Treating Solitary, Unilateral, and Proximal Ureteral Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to determine the preoperative predictors of sepsis after percutaneous nephrolithotomy
      (PCNL) in patients with unilateral, solitary and proximal ureteral stones.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">February 20, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sepsis</measure>
    <time_frame>within 48 hour after surgery</time_frame>
    <description>the concurrence of infection and a minimum of two of the following within 48 hours of surgery: (1) heart rate &gt;90/minute, (2) body temperature &gt;38°C, (3) leukocyte count &lt;4,000 cells/μL or &gt;12,000 cells/μL, and (4) respiratory rate &gt;20/minute</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">745</enrollment>
  <condition>Percutaneous Nephrolithotomy</condition>
  <condition>Infection</condition>
  <condition>Urolithiasis</condition>
  <condition>Albumin Globulin Ratio</condition>
  <arm_group>
    <arm_group_label>proximal ureteral stone patient</arm_group_label>
    <description>Patients underwent percutaneous nephrolithotomy treating unilateral, solitary and proximal ureteral stones.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>percutaneous nephrolithotomy</intervention_name>
    <description>percutaneous surgery using nephroscope</description>
    <arm_group_label>proximal ureteral stone patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 745 patients who underwent PCNL from January 2012 to December 2018 were enrolled
        when meeting eligibility criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (1) PCNL was performed to treat unilateral, solitary, and proximal ureteral stones;
             and (2) age ≥18 years

        Exclusion Criteria:

          -  anatomical renal abnormalities (horseshoe kidney, solitary kidney, transplant kidney
             and kidney duplication)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Li Cong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data is not suitable to be public</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

